Author pages are created from data sourced from our academic publisher partnerships and public sources.
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.
Hepatocellular carcinoma (HCC) is a neoplasm the incidence of which is increasing worldwide, but striking geographical differences are observed for both risk factors and occurrence . HCC… Expand
Transarterial Therapy for Hepatocellular Carcinoma: Which Technique Is More Effective? A Systematic Review of Cohort and Randomized Studies
- L. Marelli, R. Stigliano, +7 authors A. Burroughs
- CardioVascular and Interventional Radiology
- 15 February 2007
BackgroundChemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, or whether embolization (TAE) alone gives the same survival… Expand
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).
Royal Free Hospital, London, UKIntroductionBackground of the European Liver Transplant RegistrySince 1968 the European Liver Transplant Registry (ELTR) collectsprospectively the data of liver… Expand
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy.
- E. Tsochatzis, K. Gurusamy, S. Ntaoula, E. Cholongitas, B. Davidson, A. Burroughs
- Journal of hepatology
- 1 April 2011
BACKGROUND & AIMS Transient elastography is a non-invasive method, for the assessment of hepatic fibrosis, developed as an alternative to liver biopsy. We studied the performance of elastography for… Expand
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization.
BACKGROUND & AIMS Standard RECIST criteria may not be the optimal method to assess response to loco-regional therapy for hepatocellular cancer (HCC). EASL and mRECIST, which measure changes in… Expand
A Systematic Review of Microvascular Invasion in Hepatocellular Carcinoma: Diagnostic and Prognostic Variability
- M. Rodríguez-Perálvarez, T. Luong, L. Andreana, T. Meyer, A. Dhillon, A. Burroughs
- Annals of Surgical Oncology
Selected patients with hepatocellular carcinoma are candidates to receive potentially curative treatments, such as hepatic resection or liver transplantation, but nevertheless there is a high risk of… Expand
Transjugular liver biopsy--indications, adequacy, quality of specimens, and complications--a systematic review.
Transjugular liver biopsy (TJLB) is considered an inferior biopsy, used when percutaneous liver biopsy (PLB) is contraindicated. According to recent literature, specimens with 6 complete portal… Expand
Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013.
Bacterial infections are very common and represent one of the most important reasons of progression of liver failure, development of liver-related complications, and mortality in patients with… Expand
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.
BACKGROUND & AIMS A staged prognostic model of cirrhosis based on varices, ascites, and bleeding has been proposed. We analyzed data on infections in patients with cirrhosis to determine whether it… Expand